Who should we test for COVID-19? A triage model built from national symptom surveys
Saar Shoer, Tal Karady, Ayya Keshet, Smadar Shilo, Hagai Rossman, Amir Gavrieli, Tomer Meir, Amit Lavon, Dmitry Kolobkov, Iris Kalka, Anastasia Godneva, Ori Cohen, Adam Kariv, Ori Hoch, Mushon Zer-Aviv, Noam Castel, Anat Ekka Zohar, Angela Irony, Benjamin Geiger, Dorit Hizi, Varda Shalev, Ran Balicer, Eran Segal
doi: https://doi.org/10.1101/2020.05.18.20105569
Saar Shoer
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Tal Karady
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Ayya Keshet
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Smadar Shilo
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
3Pediatric Diabetes Unit, Ruth Rappaport Children’s Hospital, Rambam Healthcare Campus, Haifa, Israel
Hagai Rossman
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Amir Gavrieli
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Tomer Meir
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Amit Lavon
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Dmitry Kolobkov
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Iris Kalka
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Anastasia Godneva
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Ori Cohen
Adam Kariv
4The public knowledge workshop, Tel Aviv, Israel
Ori Hoch
4The public knowledge workshop, Tel Aviv, Israel
Mushon Zer-Aviv
4The public knowledge workshop, Tel Aviv, Israel
Noam Castel
4The public knowledge workshop, Tel Aviv, Israel
Anat Ekka Zohar
5Epidemiology and Database Research Unit, Maccabi Healthcare Services, Tel Aviv, Israel
Angela Irony
5Epidemiology and Database Research Unit, Maccabi Healthcare Services, Tel Aviv, Israel
Benjamin Geiger
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Dorit Hizi
4The public knowledge workshop, Tel Aviv, Israel
Varda Shalev
5Epidemiology and Database Research Unit, Maccabi Healthcare Services, Tel Aviv, Israel
8School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Ran Balicer
7Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel
Eran Segal
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Posted May 21, 2020.
Who should we test for COVID-19? A triage model built from national symptom surveys
Saar Shoer, Tal Karady, Ayya Keshet, Smadar Shilo, Hagai Rossman, Amir Gavrieli, Tomer Meir, Amit Lavon, Dmitry Kolobkov, Iris Kalka, Anastasia Godneva, Ori Cohen, Adam Kariv, Ori Hoch, Mushon Zer-Aviv, Noam Castel, Anat Ekka Zohar, Angela Irony, Benjamin Geiger, Dorit Hizi, Varda Shalev, Ran Balicer, Eran Segal
medRxiv 2020.05.18.20105569; doi: https://doi.org/10.1101/2020.05.18.20105569
Who should we test for COVID-19? A triage model built from national symptom surveys
Saar Shoer, Tal Karady, Ayya Keshet, Smadar Shilo, Hagai Rossman, Amir Gavrieli, Tomer Meir, Amit Lavon, Dmitry Kolobkov, Iris Kalka, Anastasia Godneva, Ori Cohen, Adam Kariv, Ori Hoch, Mushon Zer-Aviv, Noam Castel, Anat Ekka Zohar, Angela Irony, Benjamin Geiger, Dorit Hizi, Varda Shalev, Ran Balicer, Eran Segal
medRxiv 2020.05.18.20105569; doi: https://doi.org/10.1101/2020.05.18.20105569
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2642)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12212)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4088)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2647)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3865)
- Nursing (209)
- Nutrition (577)
- Oncology (2025)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1399)
- Respiratory Medicine (871)
- Rheumatology (406)
- Sports Medicine (342)
- Surgery (445)
- Toxicology (52)
- Transplantation (185)
- Urology (165)